Condition

Esophageal Carcinoma

ClinicalTrials.gov condition label

Clinical trials25

Recruiting8

Common interventions25

Lead sponsors shown15

Clinical trials

25 shown

The Vanguard Study: Testing a New Way to Screen for CancerNCT06995898 · 2025-06-18

PET-imaging of Two Vartumabs in Patients With Solid TumorsNCT06645808 · 2024-12-10

Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) ProgramNCT06265285 · 2024-04-30

Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Patients With Taxans-resistant Pancreatic Adenocarcinoma, Cholangiocarcinoma, Lung Cancer, Gastric Cancer, Esophageal Carcinoma, or Breast CancerNCT06199895 · 2023-11-28

PET/CT Imaging to Evaluate Cardiac Radiation Damage in Patients With Lung or Esophageal Cancer, EUCLID TrialNCT05775939 · 2023-01-20

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy EvaluationNCT05059444 · 2021-09-07

Dyadic Yoga Intervention in Improving Physical Performance and Quality of Life in Patients With Stage I-IV Non-small Cell Lung or Esophageal Cancer Undergoing Radiotherapy and Their CaregiversNCT03948100 · 2018-12-20

Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton TherapyNCT00991094 · 2005-05-27

Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic CancersNCT07118176 · 2025-08-01

ACTIVE_NOT_RECRUITING

Defining Musical Toxicity and Its Effect on Patient Well-beingNCT06494046 · 2024-08-15

Thalidomide Prevention or Treatment of Camrelizumab-induced Reactive Cutaneous Capillary Endothelial Proliferation (RCCEP)NCT06231680 · 2024-01-19

A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid TumorsNCT05795595 · 2023-03-13

National Cancer Institute "Cancer Moonshot Biobank"NCT04314401 · 2020-11-11

ACTIVE_NOT_RECRUITING

Randomised Trial Evaluating the Benefit of a Fitness Tracker Based Workout During RadiotherapyNCT04517019 · 2020-08-01

Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer TissuesNCT04147494 · 2019-11-05

ACTIVE_NOT_RECRUITING

Yoga Program for Improving the Quality of Life in Couples Coping With CancerNCT04607590 · 2019-05-31

ACTIVE_NOT_RECRUITING

A Clinical Research of CAR T Cells Targeting EpCAM Positive CancerNCT03013712 · 2017-01-01

Study of Pembrolizumab (MK-3475) Versus Investigator's Choice of Chemotherapy for Participants With Advanced Esophageal/Esophagogastric Junction Carcinoma That Progressed After First-Line Therapy (MK-3475-181/KEYNOTE-181)-China Extension StudyNCT03933449 · 2016-12-29

Study of Pembrolizumab (MK-3475) in Previously-Treated Participants With Advanced Carcinoma of the Esophagus or Esophagogastric Junction (MK-3475-180/KEYNOTE-180)NCT02559687 · 2015-12-02

Study of Pembrolizumab (MK-3475) Versus Investigator's Choice Standard Therapy for Participants With Advanced Esophageal/ Esophagogastric Junction Carcinoma That Progressed After First-Line Therapy (MK-3475-181/KEYNOTE-181)NCT02564263 · 2015-12-01

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)NCT02465060 · 2015-08-17

ACTIVE_NOT_RECRUITING

Doxepin Hydrochloride in Treating Esophageal Pain in Patients With Thoracic Cancer Receiving Radiation Therapy to the Thorax With or Without ChemotherapyNCT02062632 · 2014-04-14

Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney DysfunctionNCT01366144 · 2011-06-20

ACTIVE_NOT_RECRUITING

Narrow Band Imaging (NBI): A Novel Imaging Modality in Minimally InvasiveNCT01262040 · 2010-12-14

Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.NCT00423254 · 2007-02-01

Common interventions

Leading sponsors

National Cancer Institute (NCI)4 M.D. Anderson Cancer Center3 Mayo Clinic3 Merck Sharp & Dohme LLC3 Jonsson Comprehensive Cancer Center2 CRISPR Therapeutics AG1 First Affiliated Hospital of Chengdu Medical College1 Guardant Health, Inc.1 Henan Cancer Hospital1 Liu Huang1 Mannkind Corporation1 Memorial Sloan Kettering Cancer Center1 Thomas Jefferson University1 University Hospital Tuebingen1 Var2 Pharmaceuticals1

Trial status mix

RECRUITING8

ACTIVE_NOT_RECRUITING6

COMPLETED6

UNKNOWN3

TERMINATED1

WITHDRAWN1

Phase mix

PHASE28

NA6

PHASE15

EARLY_PHASE12

PHASE32

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.